2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 1g

1/? first red plate 530 nm in slide for incident illumination of iScope models for polarization

N,N-Diisopropylethylamine>99.0%(GC)500mL

Ethyl 2-(6-hydroxypyridin-3-yl)acetate, 95.0%, 250mg

tert-Butyl 3-amino-1H-1,2,4-triazole-1-carboxylate, 95%, 100mg

2-Bromo-5-fluoropyridine, 98.0%, 5g

2-Bromo-5-nitro-3-(trifluoromethyl)pyridine, 95.0%, 5g

6-Chloro-2-ethoxy-3-nitropyridine, 95+%, 250mg

1-(3-BROMOPYRIDIN-2-YL)CYCLOPROPANECARBONITRILE, 95.0%, 100mg

1,1-Diphenylethanol, 95.0%, 500g

(R)-tert-Butyl 3-cyclopropaneamidopiperidine-1-carboxylate, 95.0%, 1g

Potassium (2-chloro-4-fluorobenzyl)trifluoroborate, 98%, 250mg

Campylobacter Agar, blood-free (Base)